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Abstract
We tested the efficacy of nine different intervention strategies to minimize losses associated with experimental
coinfection of nursery age pigs with porcine reproductive and respiratory syndrome virus (PRRSV) and
Streptococcus suis. The antibimicrobials tested included penicillin, ampicillin, tiamulin, and ceftiofur
hydrochloride. Vaccines tested included two commercial modified live PRRSV vaccines, an autogenous killed
S. suis vaccine, and an experimental live autogenous S. suis vaccine. We found that the most effective
treatment was intramuscular injection of 5 mg/kg ceftiofur hydrochloride on three consecutive days following
S. suis inoculation. The live autogenous S. suis vaccine and treatment with ceftiofur hydrochloride every third
day for three treatments also significantly reduced mortality.
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Summary and Implications
We tested the efficacy of nine different intervention
strategies to minimize losses associated with experimental
coinfection of nursery age pigs with porcine reproductive
and respiratory syndrome virus (PRRSV) and
Streptococcus suis. The antibimicrobials tested included
penicillin, ampicillin, tiamulin, and ceftiofur
hydrochloride.  Vaccines tested included two commercial
modified live PRRSV vaccines, an autogenous killed S.
suis vaccine, and an experimental live autogenous S. suis
vaccine. We found that the most effective treatment was
intramuscular injection of 5 mg/kg ceftiofur hydrochloride
on three consecutive days following S. suis inoculation.
The live autogenous S. suis vaccine and treatment with
ceftiofur hydrochloride every third day for three treatments
also significantly reduced mortality.
Introduction
Mortality associated with PRRSV and Streptococcus
suis coinfection continues to be one of the major problems
in nursery age pigs.  It is estimated that 90 – 100% of all
pigs are colonized with S. suis post partum. Case
submissions to the Iowa State University Veterinary
Diagnostic Laboratory confirm a 3-fold increase in S. suis
cases and a 9-fold increase in cases of PRRSV and S. suis
coinfection during the last 5 years. We have developed an
excellent model that mimics PRRSV/S. suis coinfection in
the field (1).  This report summarizes the results from two
studies where we tested the efficacy of conventional and
experimental intervention strategies for control of PRRSV
and S. suis coinfection.
Materials and Methods
Study 1 Seventy-six, crossbred, PRRSV-free pigs were
weaned at 12 days of age and randomly assigned to seven
groups of 10 or 11 pigs each (Table 1). Pigs in group 1
served as unchallenged controls. Pigs in groups 2 – 7 were
challenged intranasally with 2 ml of high virulence PRRSV
isolate VR-2385 (104.47 TCID50/2 ml) on day 0 of the study
(30 days of age). Seven days after PRRSV challenge, pigs
in groups 2 – 7 were challenged intranasally with 2 ml of
S. suis serotype 2 (108.30 CFU/2 ml). Group 2 pigs served
as untreated positive controls. Antimicrobial treatments
included daily intramuscular injection with 66,000 IU/kg
procaine penicillin G on days 8 – 10 (group 3), drinking
water medication with 23.1 mg/kg  tiamulin during days 8-
-10 (group 4), and daily intramuscular injection of 5.0
mg/kg ceftiofur hydrochloride on days 8 – 10 (group 5).
Vaccination regimens included two intramuscular doses of
an autogenous killed S. suis vaccine (group 6) prior to S.
suis challenge, or a single 2 ml intramuscular dose of a
modified live PRRSV vaccine (group 7) 2 weeks prior to
PRRSV challenge.
Study 2  Fifty-six, crossbred, PRRSV-free pigs were
weaned at 10 – 12 days of age and randomly placed into
five groups (Table 1). All pigs received 2 ml of 106.4
TCID50/ml high virulence PRRSV isolate VR-2385
intranasally at 29 – 31 days of age on day 0 of the trial and
2 ml of 108.9 CFU/ml S. suis type 2 isolate ISU VDL
#40634/94 intranasally on day 7 of the trial. Pigs in group
1 (n=10) served as untreated positive controls. Pigs in
group 2 (n=12) received 5.0 mg/kg ceftiofur hydrochloride
(Excenel, Pharmacia & Upjohn, Kalamazoo, MI)
intramuscularly (IM) on days 8, 11, and 14. Pigs in group 3
(n=11) received 11.02 mg/kg ampicillin (Polyflex, Fort
Dodge Laboratories, Fort Dodge, IA) IM on days 8, 9, and
10. Pigs in group 4 (n=12) were vaccinated 14 days prior to
PRRSV challenge with a modified live PRRSV vaccine
(Suvaxyn PRRS, Fort Dodge Laboratories). Pigs in group
5 (n=11) were vaccinated with an experimental live
autogenous S. suis vaccine 19 days prior to S. suis
challenge.
Results and Discussion
Study 1  Mortality was 0, 63, 45, 54, 9, 40, and 81% in
groups 1 – 7, respectively (Table 1). Ceftiofur treatment
was the only regimen that significantly (P< .05) reduced
mortality associated with PRRSV and S. suis coinfection.
The other treatments and vaccinations were less effective.
We conclude that ceftiofur hydrochloride administered by
injection for three consecutive days following S. suis
challenge was the most effective regimen for minimizing
disease associated with PRRSV and S. suis coinfection.
Iowa State University Health/Food Safety
Study 2  Mortality was 80, 25, 82, 83, and 36% in groups
1 – 5 respectively (Table 1). Treatment with ceftiofur
hydrochloride and vaccination with a live autogenous S.
suis vaccine were the only treatments that significantly
reduced mortality (P<.05) associated with PRRSV/S. suis
coinfection. Pigs treated with ceftiofur hydrochloride
showed the least severe gross lung lesions. The live
autogenous S. suis vaccine had some residual virulence.
Pigs that received this vaccine had a higher incidence of
adhesions present in the serosal cavities than the ceftiofur
hydrochloride treated animals. The PRRSV/S. suis
coinfection model used represents a severe challenge
exposure in which clinical signs and lesions consistent with
PRRSV/S. suis coinfection were reproduced. The most
effective treatment was IM injection of 5 mg/kg ceftiofur
hydrochloride on three consecutive days following S. suis
inoculation. The live autogenous S. suis vaccine and
treatment with ceftiofur hydrochloride every third day for
three treatments also significantly reduced mortality.  The
other treatments did not significantly reduce mortality.
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Table 1.  Mortality associated with PRRSV and S. suis coinfection of nursery age pigs following
antimicrobial treatment or vaccination.
Group Treatment Day of Treatmenta Dose and Routeb of
Treatment
Mortality
(%)
Study 1
Group 1 Negative Controls - - 0
Group 2 Positive Controls - - 63
Group 3 penicillin 8,9,10 66,000 IU/kg IM 45
Group 4 tiamulin 8,9,10 23.1 mg/kg in drinking water 54
Group 5 ceftiofur hydrochloride 8,9,10 5.0 mg/kg IM 9c
Group 6 autogenous killed S. suis vaccine -18, -4 2 ml IM 40
Group 7 modified live PRRSV vaccine #1 -14 2 ml IM 81
Study 2
Group 1 Positive Controls - - 80
Group 2 ceftiofur hydrochloride 8,11,14 5.0 mg/kg IM 25c
Group 3 ampicillin 8,9,10 11.02 mg/kg IM 82
Group 4 modified live PRRSV vaccine #2 -14 2 ml IM 83
Group 5 experimental live S. suis vaccine -12 2 ml IN 36c
aPigs were intranasally inoculated with PRRSV on day 0 and S. suis on day 7.
b IM = Intramuscular, IN = Intranasal.
c Treatments significantly (P<.05) reduced mortality.
